|Bid||0.00 x 28400|
|Ask||0.00 x 2100|
|Day's Range||50.94 - 51.42|
|52 Week Range||39.91 - 60.14|
|Beta (5Y Monthly)||1.30|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 05, 2021|
|Forward Dividend & Yield||2.00 (3.90%)|
|Ex-Dividend Date||Apr 28, 2021|
|1y Target Est||119.69|
Bayer Aktiengesellschaft (BAYRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Merck (MRK)/Bayer's (BAYRY) vericiguat gets approval for symptomatic chronic heart failure in patients with reduced ejection fraction in Europe.
Monheim – Bayer announced the European launch of its global Carbon Initiative. The main goal is the decarbonization of the food value chain focusing on farmers’ activities for a more resilient and ...